Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking

Area of Science:

• Cardiovascular Science
• Inflammation Biology
• Oxidative Stress Research

Background:

• Cigarette smoking rapidly induces vascular inflammation, characterized by leukocyte adhesion and aggregate formation.
• Platelet-activating factor (PAF) receptor antagonists inhibit these smoke-induced vascular changes.
• PAF-like mediators accumulate in smokers' blood, distinct from biosynthetic PAF.

Purpose of the Study:

• To investigate the molecular mechanism linking cigarette smoke exposure to rapid inflammatory vascular changes.
• To determine if PAF-like lipids are responsible for smoke-induced leukocyte and platelet aggregation.
• To assess the potential of vitamin C as a dietary intervention against smoking-related inflammation.

Main Methods:

• Exposing hamsters to cigarette smoke and analyzing blood for PAF-like mediators.
• Utilizing PAF receptor antagonists to block smoke-induced vascular effects in vivo.
• Treating isolated human monocytes and platelets with PAF-like lipids to assess aggregation and cytokine release.
• Administering dietary vitamin C supplementation to smoke-exposed hamsters.

Main Results:

• Cigarette smoke exposure led to the accumulation of nonenzymatic, oxidized phospholipid mediators (PAF-like lipids).
• These PAF-like lipids induced human monocyte and platelet aggregation, increasing IL-8 and macrophage inflammatory protein-1alpha secretion.
• PAF receptor antagonism in vivo blocked smoke-induced leukocyte aggregation and vascular adhesion.
• Vitamin C supplementation prevented PAF-like lipid accumulation and smoke-induced vascular inflammatory changes.

Conclusions:

• Oxidized phospholipid mediators (PAF-like lipids) are a key mechanism linking cigarette smoke to acute vascular inflammation.
• Inhibition of PAF-like lipid formation and their downstream effects by vitamin C offers a potential dietary strategy to reduce cardiovascular disease risk in smokers.